Stock Research for CARA

CARA

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

CARA Stock Chart & Research Data

The CARA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CARA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


CARA Due diligence Resources & Stock Charts

The CARA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CARA Detailed Price Forecast - CNN Money CNN View CARA Detailed Summary - Google Finance
Yahoo View CARA Detailed Summary - Yahoo! Finance Zacks View CARA Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View CARA Trends & Analysis - Trade-Ideas Barrons View CARA Major Holders - Barrons
NASDAQ View CARA Call Transcripts - NASDAQ Seeking View CARA Breaking News & Analysis - Seeking Alpha
Spotlight View CARA Annual Report - CompanySpotlight.com OTC Report View CARA OTC Short Report - OTCShortReport.com
TradeKing View CARA Fundamentals - TradeKing Charts View CARA SEC Filings - Bar Chart
WSJ View Historical Prices for CARA - The WSJ Morningstar View Performance/Total Return for CARA - Morningstar
MarketWatch View the Analyst Estimates for CARA - MarketWatch CNBC View the Earnings History for CARA - CNBC
StockMarketWatch View the CARA Earnings - StockMarketWatch MacroAxis View CARA Buy or Sell Recommendations - MacroAxis
Bullish View the CARA Bullish Patterns - American Bulls Short Pains View CARA Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View CARA Stock Mentions - StockTwits PennyStocks View CARA Stock Mentions - PennyStockTweets
Twitter View CARA Stock Mentions - Twitter Invest Hub View CARA Investment Forum News - Investor Hub
Yahoo View CARA Stock Mentions - Yahoo! Message Board Seeking Alpha View CARA Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for CARA - SECform4.com Insider Cow View Insider Transactions for CARA - Insider Cow
CNBC View CARA Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CARA - OTC Markets
Yahoo View Insider Transactions for CARA - Yahoo! Finance NASDAQ View Institutional Holdings for CARA - NASDAQ


Stock Charts

FinViz View CARA Stock Insight & Charts - FinViz.com StockCharts View CARA Investment Charts - StockCharts.com
BarChart View CARA Stock Overview & Charts - BarChart Trading View View CARA User Generated Charts - Trading View




Latest Financial News for CARA


Cara Therapeutics (CARA) Reports Q2 Loss, Tops Revenue Estimates
Posted on Monday August 08, 2022

Cara (CARA) delivered earnings and revenue surprises of 71.43% and 8.08%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?


Cara Therapeutics Reports Second Quarter 2022 Financial Results
Posted on Monday August 08, 2022

– Net revenue was $23M for 2Q 2022 comprised of profit-sharing revenue of $8M from KORSUVA™ (difelikefalin) injection and a $15M milestone payment from the European Commission approval of Kapruvia® (difelikefalin) – – KOMFORT Phase 2 trial met primary endpoint in notalgia paresthetica, validating potential broad utility of oral difelikefalin across multiple disease categories; FDA meeting expected in 2H 2022 – – Conference call today at 4:30 p.m. ET – STAMFORD, Conn., Aug. 08, 2022 (GLOBE NEWSWI


Should You Buy Cara Therapeutics (CARA) Ahead of Earnings?
Posted on Thursday August 04, 2022

Cara Therapeutics (CARA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.


Cara Therapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference
Posted on Wednesday August 03, 2022

STAMFORD, Conn., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced that Christopher Posner, President and Chief Executive Officer, will present at the Canaccord Genuity 42nd Annual Growth Conference on Wednesday, August 10, 2022, at 9:30 a.m. ET. A webcast of the presentation can be accessed under "Events & Presentations"


Stock Market & Investing Books

Enter a stock symbol to view the stock details.